Genomic Tumor Testing To Match Lung Cancer Patients With Targeted Drugs Transforms Care
Tuesday, May 20, 2014 - 19:03
in Health & Medicine
NEW YORK, May 20, 2014 — New data from a study led by Memorial Sloan Kettering physicians that used targeted therapy for patients with the most common type of lung cancer has helped transform treatment for the disease. read more